Unknown

Dataset Information

0

Total synthesis of remdesivir.


ABSTRACT: Remdesivir, the first drug approved by the FDA to treat COVID-19, is in high demand for patients infected with the SARS-CoV-2 virus. Herein, we report a facile approach minimizing the protecting group manipulations to afford remdesivir in good overall yield.

SUBMITTER: Kumar Palli K 

PROVIDER: S-EPMC8656175 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7536717 | biostudies-literature
| S-EPMC9366944 | biostudies-literature
| S-EPMC7304253 | biostudies-literature
| S-EPMC1480405 | biostudies-literature
| S-EPMC2546581 | biostudies-literature
| S-EPMC2838230 | biostudies-literature
| S-EPMC2775134 | biostudies-literature
| S-EPMC5484051 | biostudies-literature
| S-EPMC3269829 | biostudies-literature
| S-EPMC4941107 | biostudies-literature